| In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion PW Szlosarek, A Klabatsa, A Pallaska, M Sheaff, P Smith, T Crook, ... Clinical cancer research 12 (23), 7126-7131, 2006 | 229 | 2006 |
| Prognostic factors in mesothelioma JPC Steele, A Klabatsa, DA Fennell, A Palläska, MT Sheaff, MT Evans, ... Lung Cancer 49, S49-S52, 2005 | 114 | 2005 |
| Mesothelin-targeted CAR-T cell therapy for solid tumors A Klampatsa, V Dimou, SM Albelda Expert opinion on biological therapy 21 (4), 473-486, 2021 | 102 | 2021 |
| Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study. Modern Pathology 31 (4), 598-606, 2018 | 96 | 2018 |
| Fibroblast activation protein (FAP)-targeted CAR-T cells: launching an attack on tumor stroma R Bughda, P Dimou, RR D’Souza, A Klampatsa ImmunoTargets and Therapy, 313-323, 2021 | 89 | 2021 |
| Armored CAR T-cells: the next chapter in T-cell cancer immunotherapy ER Hawkins, RR D’Souza, A Klampatsa Biologics: Targets and Therapy, 95-105, 2021 | 83 | 2021 |
| Function of human tumor-infiltrating lymphocytes in early-stage non–small cell lung cancer SM O'Brien, A Klampatsa, JC Thompson, MC Martinez, WT Hwang, ... Cancer immunology research 7 (6), 896-909, 2019 | 83 | 2019 |
| Chemotherapy options and new advances in malignant pleural mesothelioma JPC Steele, A Klabatsa Annals of oncology 16 (3), 345-351, 2005 | 80 | 2005 |
| The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma A Klabatsa, S Chicklore, SF Barrington, V Goh, L Lang-Lazdunski, ... European journal of nuclear medicine and molecular imaging 41, 276-282, 2014 | 70 | 2014 |
| Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM) A Klabatsa, MT Sheaff, JPC Steele, MT Evans, RM Rudd, DA Fennell Lung cancer 51 (1), 53-59, 2006 | 67 | 2006 |
| Intracavitary ‘T4 immunotherapy’of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells A Klampatsa, DY Achkova, DM Davies, AC Parente-Pereira, N Woodman, ... Cancer letters 393, 52-59, 2017 | 59 | 2017 |
| CAR T-cell immunotherapy of MET-expressing malignant mesothelioma. MJ Thayaparan T, Petrovic RM, Achkova DY, Zabinski T, Davies DM, Klampatsa A ... Oncoimmunology 6 (12), e1363137, 2017 | 54 | 2017 |
| Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group SG Armato III, ZE Labby, J Coolen, A Klabatsa, M Feigen, T Persigehl, ... Lung Cancer 82 (2), 190-196, 2013 | 50 | 2013 |
| Analysis and augmentation of the immunologic bystander effects of CAR T cell therapy in a syngeneic mouse cancer model A Klampatsa, MS Leibowitz, J Sun, M Liousia, E Arguiri, SM Albelda Molecular Therapy-Oncolytics 18, 360-371, 2020 | 43 | 2020 |
| Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes A Klampatsa, SM O’Brien, JC Thompson, AS Rao, JE Stadanlick, ... Oncoimmunology 8 (9), e1638211, 2019 | 41 | 2019 |
| Resistance to HSP90 inhibition involving loss of MCL1 addiction S Busacca, EWP Law, IR Powley, DA Proia, M Sequeira, J Le Quesne, ... Oncogene 35 (12), 1483-1492, 2016 | 37 | 2016 |
| Chimeric antigen receptor (CAR) T cell therapy for malignant pleural mesothelioma (MPM) A Klampatsa, AR Haas, EK Moon, SM Albelda Cancers 9 (9), 115, 2017 | 33 | 2017 |
| Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis T Kimura, J Monslow, A Klampatsa, M Leibowitz, J Sun, M Liousia, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 317 (2 …, 2019 | 29 | 2019 |
| Luminol Chemiluminescence Reports Photodynamic Therapy‐Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic Efficacy RW Davis IV, E Snyder, J Miller, S Carter, C Houser, A Klampatsa, ... Photochemistry and photobiology 95 (1), 430-438, 2019 | 28 | 2019 |
| BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma S Busacca, AD Chacko, A Klabatsa, K Arthur, M Sheaff, ... PloS one 8 (6), e65489, 2013 | 18 | 2013 |
